Horizon 2020 (2014 - 2020)

Dedicated support to biotechnology SMEs closing the gap from lab to market, Phase 1

Last update: Apr 27, 2023 Last update: 27 Apr, 2023

Details

Location:EU 27, SwitzerlandEU 27, Switzerland
Contracting Authority Type:Development Institution
Status:Awarded
Budget:EUR 750,000
Award ceiling:N/A
Award floor:N/A
Sector:Laboratory & Measurement, Science & Innovation, SME & Private Sector
Languages:English
Eligible applicants:Unrestricted / Unspecified
Eligible nationalities:Afghanistan, Albania, Algeria, A ... See moreAfghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Argentina, Armenia, Aruba, Austria, Azerbaijan, Azores, Bangladesh, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, British Virgin Islands, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canary Islands, Cape Verde, Caribbean Netherlands, Cayman Islands, Central African Republic, Chad, Chile, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Romania, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Seychelles, Sierra Leone, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Turks and Caicos, Tuvalu, Uganda, Ukraine, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted:15 Oct, 2015

Attachments 11

Description

Call Updates:

19 December 2017 23:26

An overview of the evaluation results (flash call info - 07-11-2017 cut-off - Phase I) is now available under the Call 'Additional documents' tab.

10 November 2017 13:08

Following the postponed deadline for the SME-1 (Phase I) November 7th 2017 cut-off (H2020-SMEINST-1-2017_07-11-2017), there are currently a total of 2596 proposals submitted. The number of proposals for this topic is shown below:

SMEInst-03-2016-2017   108

08 November 2017 16:29

Due to a misleading communication on the closing date of the SME Instrument call, the deadline of the call has been postponed to 09/11/2017, 17:00 Brussels time. You can review, edit and submit your proposal at any time before the new deadline from My Proposals tab (https://ec.europa.eu/research/participants/portal/desktop/en/proposals/index.html) in the Participant Portal.

08 November 2017 15:45

The submission session is now available for: SMEInst-03-2016-2017(SME-1)

08 November 2017 10:28

A total number of 2470 proposals were submitted in response to the SME-1 (Phase I) November 7th 2017 cut-off (H2020-SMEINST-1-2017_07-11-2017). The number of proposals for this topic is shown below:

SMEInst-03-2016-2017   104

03 November 2017 11:05

REMINDER: Please note that due to the opening of the EIC Pilot calls (2018-2020), the final cut-off date of the SME Instrument call for Phase 1 in 2017, has been brought forward to the 7th of November 2017 at 17:00:00 (Brussels time).

The cut-off date of November 8th set out in the Work Programme no longer applies.

17 October 2017 16:07

An overview of the evaluation results (flash call info - 06-09-2017 cut-off - Phase I) is now available under the Call 'Additional documents' tab.

07 September 2017 09:47

A total number of 2130 proposals were submitted in response to the SME-1 (Phase I) September 6th 2017 cut-off (H2020-SMEINST-1-2017_06-09-2017). The number of proposals for this topic is shown below:

SMEInst-03-2016-2017    90

05 September 2017 17:30

Please note that due to the opening of the EIC Pilot calls (2018-2020), the final cut-off date of the SME Instrument call for Phase 1 in 2017, has been brought forward to the 7th of November 2017 at 17:00:00 (Brussels time).

The cut-off date of November 8th set out in the Work Programme no longer applies.  

16 June 2017 08:31

An overview of the evaluation results (flash call info - 03-05-2017 cut-off - Phase I) is now available under the Call 'Additional documents' tab.

03 May 2017 17:44

A total number of 2165 proposals were submitted in response to the SME-1 (Phase I) May 3rd 2017 cut-off (H2020-SMEINST-1-2017_03-05-2017).The number of proposals for this topic is shown below:

SMEInst-03-2016-2017- 91

04 April 2017 12:23

An overview of the evaluation results (flash call info - 15-02-2017 cut-off - Phase I) is now available under the Call 'Additional documents' tab.

02 March 2017 16:54

The part B templates for SME phase1 and SME phase 2 have been updated. They now include an additional bullet point under section 2.1.a "expected impacts" relating to addressing climate change and the environment and bringing other important benefits to society.

The new templates can be viewed by clicking on the above links. Alternatively, you may download them at 'Step 3' of the submission process on the left-hand side of the screen(Download Part B Templates).

21 February 2017 17:18

The part B templates for SME phase1 and SME phase 2 have been updated. They now include an additional bullet point under section 2.1.a "expected impacts" relating to addressing climate change and the environment and bringing other important benefits to society.

The new templates can be downloaded at 'Step 3' of the submission process on the left-hand side of the screen(Download Part B Templates). They will also soon feature in the " Proposal templates" folder of the Reference documents page of the H2020 Participants Portal.

16 February 2017 10:56

A total number of 2111 proposals were submitted in response to the SME-1 (Phase I) February 15th 2017 cut-off (H2020-SMEINST-1-2017_15-02-2017). The number of proposals for this topic is shown below:

SMEInst-03-2016-2017: 87 proposals

07 February 2017 17:08

Please note that on 2 February  2017, a updated version of the standard Self-Evaluation forms for SME Instrument phase 1 and SME Instrument phase 2 have been published. 

07 February 2017 16:27

On 6 November 2016, Armenia became an associated country.

17 January 2017 10:57

Reminders:

1) The Evaluation Summary Reports (ESRs) and scores received from similar proposals submitted in different cut-off dates may differ, sometimes substantially, based on different opinions and judgments from independent experts.

2) Please have your SME status validated or renewed well ahead of the submission date.

06 January 2017 17:15

As of 1 January 2017, Switzerland is fully associated to H2020.

14 December 2016 18:52

An overview of the evaluation results (flash call info - 09-11-2016 cut-off - Phase I) is now available under the Call 'Additional documents' tab.

21 October 2016 14:42

An overview of the evaluation results (flash call info - 07-09-2016 cut-off -Phase I) is now available under the Call 'Additional documents' tab.

09 September 2016 13:34

A total number of 1.938 proposals were submitted in response to the SME-1 (Phase I) September 7th 2016 cut-off (H2020-SMEINST-1-2016_07_09_2016). The number of proposals for this topic is shown below: SMEInst-03-2016-2017 - 65

02 September 2016 16:42

Reminders:

1) The Evaluation Summary Reports (ESRs) and scores received from similar proposals submitted in different cut-off dates may differ, sometimes substantially, based on different opinions and judgments from independent experts.

2) Please have your SME status validated or renewed well ahead of the submission date.

03 August 2016 15:06

Please note that, as a result of a recent technical update, following the self-assessment of the SME status, confirmation thereof will take into consideration the closing date of the accounts for the financial year on which the assessment of the SME status was based. The confirmation of the SME status applies for two years.

By way of example, if a legal entity performs the self-assessment in the 'Beneficiary Register', with closing date of its accounts for the financial year on March 31st 2015, confirmation of the SME status will be considered until March 31st 2017. Therefore, a legal entity which would like to submit a proposal for a cut-off date in April 2017, would need to perform a new self-assessment.

21 June 2016 16:57

An overview of the evaluation results (flash call info - 03-05-2016 cut-off -Phase I) is now available under the Call 'Additional documents' tab.

14 June 2016 09:20

Reminders:

1) The Evaluation Summary Reports (ESRs) and scores received from similar proposals submitted in different cut-off dates may differ, sometimes substantially, based on different opinions and judgments from independent experts.

2) Please have your SME status validated or renewed well ahead of the submission date.

06 June 2016 15:39

Reminder: The Evaluation Summary Reports (ESRs) and scores received from similar proposals submitted in different cut-off dates may differ, sometimes substantially, based on different opinions and judgments from independent experts.

10 May 2016 11:14

A total number of 2,005 proposals were submitted in response to the SME-1 (Phase I) May 3rd 2016 cut-off (H2020-SMEINST-1-2016_03_05_2016). The number of proposals for this topic is shown below:

SMEInst-03-2016-2017 - 58

02 May 2016 16:43

Dear applicants,

Please remember to have your SME status validated or renewed well ahead of the submission date.

19 April 2016 10:22

An overview of the evaluation results (flash call info - 24-02-2016 cut-off -Phase I) is now available under the Call 'Additional documents' tab.

08 April 2016 14:51

Dear applicants,

Please remember to have your SME status validated or renewed well ahead of the submission date.

25 February 2016 10:47

A total number of 1995 proposals were submitted in response to the SME-1 (Phase I) February 24th 2016 cut-off (H2020-SMEINST-1-2016_24_02_216). The number of proposals for this topic is shown below:

SMEInst-03-2016-2017 = 46.

26 November 2015 00:30 The submission session is now available for: SMEInst-03-2016-2017(SME-1)


TOPIC : Dedicated support to biotechnology SMEs closing the gap from lab to market

Topic identifier: SMEInst-03-2016-2017
Publication date: 14 October 2015

Types of action: SME-1 SME instrument phase 1
DeadlineModel:
Opening date:
multiple cut-off
26 November 2015
Cut-off dates: 24 February 2016 17:00:00
03 May 2016 17:00:00
07 September 2016 17:00:00
09 November 2016 17:00:00
15 February 2017 17:00:00
03 May 2017 17:00:00
06 September 2017 17:00:00
08 November 2017 17:00:00

Time Zone : (Brussels time)
 
  Horizon 2020
Pillar: Industrial Leadership
Work Programme Year: H2020-2016-2017
Work Programme Part: Innovation in SMEs
Call : H2020-SMEInst-2016-2017

 
Topic Description

Specific Challenge:The large numbers of SMEs characterising the EU industrial biotechnology sector are playing a crucial role in the move to competitive and sustainable biotechnology-based processes. These SMEs are characterised by their research intensity and long lead times between early technological development and market introduction. They therefore need to be supported to overcome the so-called “valley of death”. SMEs working in the field of industrial biotechnology and ideas/concepts involving the use of systems and/or synthetic biology are particularly invited to apply for funding.

Scope:The SME instrument consists of three phases, including a coaching and mentoring service for beneficiaries. Participants can apply to phase 1 or directly to phase 2.

In phase 1, a feasibility study shall be developed in order to verify the technological/practical as well as economic viability of an innovation idea/concept with considerable novelty to the industry sector in which it is presented (new products, processes, design, services and technologies or new market applications of existing technologies). The activities could, for example, comprise risk assessment, market study, user involvement, Intellectual Property (IP) management[1],

innovation strategy development, partner search, feasibility of concept and the like to establish a solid high-potential innovation project aligned to the enterprise strategy and with a European dimension. Bottlenecks in the ability to increase profitability of the enterprise through innovation shall be detected and analysed during phase 1 and addressed during phase 2 to increase the return in investment in innovation activities. The proposal should contain an initial business plan based on the proposed idea/concept. It should outline the specifications of a more elaborate business plan, which is to be the outcome of the project, and the criteria for success.

Funding will be provided in the form of a lump sum of EUR 50.000. Projects should last around 6 months.

In phase 2, innovation projects[2]

will be supported that address the specific challenges identified and that demonstrate high potential in terms of company competitiveness and growth underpinned by a strategic business plan. Activities should focus on innovation activities such as demonstration, testing, prototyping, piloting, scaling-up, miniaturisation, design, market replication and the like aiming to bring an innovation idea (product, process, service etc.) to industrial readiness and maturity for market introduction, but may also include some research. For technological innovation, Technology Readiness Levels of 6 or above (or similar for non-technological innovations) are envisaged; please see part G of the General Annexes.

Proposals shall be based on an elaborate business plan. Particular attention must be paid to IP protection and ownership; applicants will have to present convincing measures to ensure the possibility of commercial exploitation ('freedom to operate').

Proposals shall contain a specification for the outcome of the project and criteria for success. They will include an explanation of how the results of the supported project are to be commercialised and of what kind of impact on the company is expected.

The Commission considers that proposals requesting a contribution from the EU of between EUR 0.5 and 2.5 million[3]

would allow phase 2 to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts (higher or lower). Projects should last between 12 and 24 months.

Phase 3 of the SME Instrument aims to increase the economic impact of the funding provided by the SME Instrument phase 1&2 grants and by the business coaching. Phase 3 is not subsequent to phase 1 and/or 2, but provides specific support to SME instrument beneficiaries during and after phase 1 or 2.

All support under phase 3 of the SME instrument will be accessible through a single, dedicated entry point, which will serve as an information portal and a networking space.

This platform will offer access to two main strands of services:

Access to markets
Access to finance
In addition, phase 3 will create opportunities for partnering, networking and training, which are set out in the Dedicated Support Actions at the end of this call.

SME instrument beneficiaries are also offered dedicated business innovation coaching and mentoring support. This service is facilitated by the Enterprise Europe Network and delivered by a dedicated coach through consultation and signposting to the beneficiaries. The coaches are recruited from a central database managed by the Commission and have all fulfilled stringent criteria with regards to business experience and competencies.

Throughout the three phases of the instrument, the Network will complement the coaching support by providing access to its innovation and internationalisation service offering. This could include, for example, depending on the need of the SME, support in identifying growth potential, developing a growth plan and maximising it through internationalisation; strengthening the leadership and management skills of individuals in the senior management team and developing in-house coaching capacity; developing a marketing strategy or raising external finance.

Expected Impact:Enhancing profitability and growth performance of SMEs by combining and transferring new and existing knowledge into innovative, disruptive and competitive solutions seizing European and global business opportunities.
Market uptake and distribution of innovations[4] tackling the specific challenges in a sustainable way.
Increase of private investment in innovation, notably leverage of private co-investor and/or follow-up investments.
The expected impacts should be clearly described in qualitative and quantitative terms (e.g. on turnover, employment, market seize, IP management, sales, return on investment and profit).
[1]This is not limited to the costs of acquiring and enforcing European or international IPR titles but could include auditing and risk management schemes to protect IP assets across planned supply and distribution chains and more generally IP valorisation plans to enhance return on investment and lever commercial investment into the relevant project.

[2]In the case of SMEInst-05-2016-2017, research type activities in medical application and clinical validation, including support for clinical studies and trials, will be predominant and will necessitate reimbursement at 100%. The Technology Readiness Levels indication does not apply.

[3]In the case of SMEInst-05-2016-2017, phase 2 proposals can request a contribution from the EU of between EUR 1 and 5 million.

[4]In the case of SMEInst-05-2016-2017, the development of innovative solutions should lead to value creation through the increased use of cell-based products/processes, biomarkers and/or diagnostic medical devices in industrial or clinical settings, and should contribute to technical and regulatory progress in these domains.

 
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits